광견병 백신 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Rabies Vaccine Trends and Forecast

The future of the global rabies vaccine market looks promising with opportunities in the hospital, homecare, and specialty clinic markets. The global rabies vaccine market is expected to reach an estimated $1.2 billion by 2030 with a CAGR of 4.4% from 2024 to 2030. The major drivers for this market are rising awareness about the risks of rabies and growing efforts to control rabies in wildlife populations, such as foxes and raccoons.

A more than 150-page report is developed to help in your business decisions.

Rabies Vaccine by Segment

The study includes a forecast for the global rabies vaccine by product type, vaccination type, application, end use, and region.

Rabies Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Baby Hamster Kidney
• Purified Chick Embryo Cell Rabies Vaccine
• Vero Cell Rabies Vaccine
• Others

Rabies Vaccine Market by Vaccination Type [Shipment Analysis by Value from 2018 to 2030]:

• Pre-Exposure Vaccination (PEV)
• Post-Exposure Prophylaxis (PEP)

Rabies Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Animal
• Human

Rabies Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Homecare
• Specialty Clinics
• Others

Rabies Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Rabies Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rabies vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rabies vaccine companies profiled in this report include-

• Serum Institute of India
• Novartis
• Cadila Pharmaceuticals
• Merck
• Sanofi
• ADS Diagnostic
• GSK

Rabies Vaccine Market Insights

Lucintel forecasts that vero cell is expected to witness highest growth over the forecast period due to its numerous benefits, such as its feasibility, safety, high immunogenicity, and can be used for pre- and post-exposure prophylaxis.

Within this market, hospital is expected to witness highest growth over the forecast period due to increasing rabies vaccination prescriptions tend to be issued within this facility.

North America will remain the largest region due to existence of robust healthcare infrastructure and expanding number of pharmaceutical companies in the region.

Features of the Global Rabies Vaccine Market

Market Size Estimates: Rabies vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rabies vaccine market size by various segments, such as by product type, vaccination type, application, end use, and region in terms of ($B).

Regional Analysis: Rabies vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, vaccination types, applications, end uses, and regions for the rabies vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rabies vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rabies vaccine market size?

Answer: The global rabies vaccine market is expected to reach an estimated $1.2 billion by 2030.

Q.2 What is the growth forecast for rabies vaccine market?

Answer: The global rabies vaccine market is expected to grow with a CAGR of 4.4% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rabies vaccine market?

Answer: The major drivers for this market are rising awareness about the risks of rabies and growing efforts to control rabies in wildlife populations, such as foxes and raccoons.

Q4. What are the major segments for rabies vaccine market?

Answer: The future of the rabies vaccine market looks promising with opportunities in the hospital, homecare, and specialty clinic markets.

Q5. Who are the key rabies vaccine market companies?

Answer: Some of the key rabies vaccine companies are as follows:

• Serum Institute of India
• Novartis
• Cadila Pharmaceuticals
• Merck
• Sanofi
• ADS Diagnostic
• GSK

Q6. Which rabies vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that vero cell is expected to witness highest growth over the forecast period due to its numerous benefits, such as its feasibility, safety, high immunogenicity, and can be used for pre- and post-exposure prophylaxis.

Q7. In rabies vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure and expanding number of pharmaceutical companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the rabies vaccine market by product type (baby hamster kidney, purified chick embryo cell rabies vaccine, vero cell rabies vaccine, and others), vaccination type (pre-exposure vaccination (PEV) and post-exposure prophylaxis (PEP)), application (animal and human), end use (hospitals, homecare, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rabies Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Rabies Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Rabies Vaccine Market by Product Type
  • 3.3.1: Baby Hamster Kidney
  • 3.3.2: Purified Chick Embryo Cell Rabies Vaccine
  • 3.3.3: Vero Cell Rabies Vaccine
  • 3.3.4: Others
• 3.4: Global Rabies Vaccine Market by Vaccination Type
  • 3.4.1: Pre-Exposure Vaccination (PEV)
  • 3.4.2: Post-Exposure Prophylaxis (PEP)
• 3.5: Global Rabies Vaccine Market by Application
  • 3.5.1: Animal
  • 3.5.2: Human
• 3.6: Global Rabies Vaccine Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Homecare
  • 3.6.3: Specialty Clinics
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Rabies Vaccine Market by Region
• 4.2: North American Rabies Vaccine Market
  • 4.2.2: North American Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.3: European Rabies Vaccine Market
  • 4.3.1: European Rabies Vaccine Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.3.2: European Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.4: APAC Rabies Vaccine Market
  • 4.4.1: APAC Rabies Vaccine Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.4.2: APAC Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.5: ROW Rabies Vaccine Market
  • 4.5.1: ROW Rabies Vaccine Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.5.2: ROW Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Rabies Vaccine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Rabies Vaccine Market by Vaccination Type
  • 6.1.3: Growth Opportunities for the Global Rabies Vaccine Market by Application
  • 6.1.4: Growth Opportunities for the Global Rabies Vaccine Market by End Use
  • 6.1.5: Growth Opportunities for the Global Rabies Vaccine Market by Region
• 6.2: Emerging Trends in the Global Rabies Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Rabies Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rabies Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Serum Institute of India
• 7.2: Novartis
• 7.3: Cadila Pharmaceuticals
• 7.4: Merck
• 7.5: Sanofi
• 7.6: ADS Diagnostic
• 7.7: GSK